Small molecule · developed by Btg International
Uridine is an acetylated prodrug of uridine (uridine triacetate) that is deacetylated in the body to yield uridine in the circulation. It competitively inhibits cell damage and cell death caused by fluorouracil by competing with its metabolite FUTP for incorporation into RNA. It is used in the emergency treatment of fluorouracil or capecitabine overdose.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Mar 31, 2026). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT00812058 | Phase 2 | Bipolar I Depression | Completed | RGEN |
| NCT00322764 | Phase 2 | Bipolar Depression | Completed | RGEN |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Bipolar DepressionBipolar I Depression
Updated Nov 1, 2026.